BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35494983)

  • 1. Secondary Immune Thrombocytopenia Due to Mycoplasma pneumoniae Without Clinically Significant Evidence of Active Infection.
    Park CL; Margaria B; Husnain M
    Cureus; 2022 Mar; 14(3):e23551. PubMed ID: 35494983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Thrombocytopenia Associated with
    Gouveia C; Evangelista V; Almeida R; Baptista AM
    Eur J Case Rep Intern Med; 2018; 5(3):000817. PubMed ID: 30756019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
    Nugent D; McMillan R; Nichol JL; Slichter SJ
    Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-system manifestations of
    Al Busaidi I; Al-Amin M; Ibrahim S; Balkhair A; Gaifer Z
    JMM Case Rep; 2017 Sep; 4(9):e005117. PubMed ID: 29114398
    [No Abstract]   [Full Text] [Related]  

  • 5. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of COVID-19-Induced Immune Thrombocytopenia (ITP) in an Adult Female: An Under-Recognized Emerging Phenomenon.
    Ghukasyan H; Petrechko O; Choi H
    Cureus; 2023 Apr; 15(4):e38173. PubMed ID: 37122979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
    Bakchoul T; Sachs UJ
    Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Thrombocytopenia (ITP): Current Limitations in Patient Management.
    Terrell DR; Neunert CE; Cooper N; Heitink-Pollé KM; Kruse C; Imbach P; Kühne T; Ghanima W
    Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33266286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of chronic immune thrombocytopenic purpura.
    McMillan R
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management.
    Singh A; Uzun G; Bakchoul T
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
    BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myocardial infarction and renal dysfunction due to chronic extreme anemia (hemoglobin 2.5 g/dL) in immune thrombocytopenia.
    Muenchrath M; Aribindi K; Farnie M; DaSilva-DeAbreu A
    Proc (Bayl Univ Med Cent); 2018 Oct; 31(4):508-510. PubMed ID: 30948994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycoplasma pneumonia Infection: A Possible Trigger for Immune Thrombocytopenia.
    Aviner S; Miskin H; London D; Horowitz S; Schlesinger M
    Indian J Hematol Blood Transfus; 2011 Mar; 27(1):46-50. PubMed ID: 22379296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review.
    Bhattacharjee S; Banerjee M
    SN Compr Clin Med; 2020; 2(11):2048-2058. PubMed ID: 32984764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood immune thrombocytopenia: Clinical presentation and management.
    Faki Osman ME
    Sudan J Paediatr; 2012; 12(1):27-39. PubMed ID: 27493327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Thrombocytopenic Purpura: A Sequelae of Mycoplasma pneumoniae Infection.
    Bonagiri P; Park D; Ingebritsen J; Valtierra DC
    Cureus; 2020 Jul; 12(7):e8955. PubMed ID: 32765999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress of study on mechanism of immune thrombocytopenic purpura and its clinical treatment - review].
    Lu XC; Zhu HL; Yao SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1232-6. PubMed ID: 18928635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune thrombocytopenia: pathophysiologic and clinical update.
    Stasi R
    Semin Thromb Hemost; 2012 Jul; 38(5):454-62. PubMed ID: 22753097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
    Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.